We are live on ! Find out more
ENFN

Enfusion, Inc.

Delisted

ENFN was delisted on the 17th of April, 2025.

109 hedge funds and large institutions have $861M invested in Enfusion, Inc. in 2024 Q3 according to their latest regulatory filings, with 19 funds opening new positions, 54 increasing their positions, 22 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

7,317% more call options, than puts

Call options by funds: $445K | Put options by funds: $6K

145% more repeat investments, than reductions

Existing positions increased: 54 | Existing positions reduced: 22

111% more first-time investments, than exits

New positions opened: 19 | Existing positions closed: 9

11% more capital invested

Capital invested by funds: $774M → $861M (+$87.9M)

8% more funds holding

Funds holding: 101109 (+8)

0% more funds holding in top 10

Funds holding in top 10: 44 (0)

Holders
109
Holders Change
+8
Holders Change %
+7.92%
% of All Funds
1.57%
Holding in Top 10
4
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.06%
New
19
Increased
54
Reduced
22
Closed
9
Calls
$445K
Puts
$6K
Net Calls
+$439K
Net Calls Change
+$36K

ENFN Hedge Fund Activity: Q3 2024 in Review

109 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in Enfusion, Inc. (ENFN) for Q3 2024, worth a combined $861M — up 11% from $774M a quarter earlier.

Buyers outnumbered sellers: 19 funds opened new ENFN positions and 9 closed out — a net gain of 10 holders — while 54 added to existing stakes and 22 trimmed.

The largest buyer was Lead Edge Capital Management, adding an estimated $5.82M. The largest seller was Brown Capital Management, cutting an estimated $11.8M.

  • 109 institutional investors held Enfusion, Inc. (ENFN) as of Q3 2024, up from 101 in Q2 2024.
  • Funds reported $861M of Enfusion, Inc. stock for Q3 2024, up 11% quarter-over-quarter.
  • 19 funds opened new Enfusion, Inc. positions in Q3 2024 and 9 closed out, a net change of +10 holders.
  • The largest Enfusion, Inc. buyer in Q3 2024 was Lead Edge Capital Management, an estimated $5.82M added.
  • The largest Enfusion, Inc. seller in Q3 2024 was Brown Capital Management, an estimated $11.8M sold.

Based on aggregated 13F filings for Q3 2024.